Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POPART'MUS: Prevention of Post-Partum MS Relapses
NCT00127075Phase 3Unknown
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2005
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nomegestrol in multiple sclerosis (MS) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Rate of relapses at 12 weeks. Status: unknown.
02
Drugs
nomegestrol
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00127075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127075.